Céline Pulcini,
Onder Ergonul,
Fusun Can,
Bojana Beović
e.a.
Elsevier Science
e druk, 2017
9780128104774
Antimicrobial Stewardship
Specificaties
Paperback, blz.
|
Engels
Elsevier Science |
e druk, 2017
ISBN13: 9780128104774
Rubricering
Onderdeel van serie
Developments in Emerging and Existing Infectious Diseases
Levertijd ongeveer 8 werkdagen
Samenvatting
Antimicrobial Stewardship (AMS), Volume Two includes the experience of ESGAP workshops and courses on antibiotic stewardship since 2012. It combines clinical and laboratory information about AMS, with a focus on human medicine.
The ESCMID study group on antibiotic policies (ESGAP) is one of the most productive groups in the field, organizing courses and workshops. This book is an ideal tool for the participants of these workshops.
With short chapters (around 1500 words) written on different topics, the authors insisted on the following points: A ‘hands on’, practical approach, tips to increase success, a description of the most common mistakes, a global picture (out- and inpatient settings, all countries) and a short list of 10-20 landmark references.
Specificaties
Inhoudsopgave
<p>Section A: The Global Picture of Antimicrobial Use and Resistance<br>1. The Global Crisis of Antimicrobial Resistance<br>2. Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance<br>3. Quality Indicators and Quantity Metrics of Antibiotic Use</p> <p>Section B: AMS Strategies<br>4. Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods<br>5. Education of Healthcare Professionals on Responsible Antimicrobial Prescribing<br>6. Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship<br>7. Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy<br>8. The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs<br>9. The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship<br>10. The Role of Pharmacists<br>11. The Roles of Nurses in Antimicrobial Stewardship<br>12. Antifungal Stewardship</p> <p>Section C: AMS in Specific Clinical Settings<br>13. Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care<br>14. Antimicrobial Stewardship: What to Tell the Patients and the General Public<br>15. Antimicrobial Stewardship in Long-Term Care Facilities<br>16. Antimicrobial Stewardship in ICU<br>17. Antimicrobial Stewardship in Hematology Patients<br>18. AMS in an Era of Multidrug-Resistant Bacteria</p> <p>Section D: AMS Experiences Around the World<br>19.1: AMS Initiatives and Policies: The International Picture<br>19.2: Missions and Objectives of EUCIC and ESGAP<br>19.3: Antimicrobial Stewardship in Latin America<br>19.4: Antimicrobial Stewardship in Australia<br>19.5: Antimicrobial Stewardship in Austria<br>19.6: Antimicrobial Stewardship in Belgium<br>19.7: Antimicrobial Stewardship in Bulgaria<br>19.8: Antimicrobial Stewardship in Croatia<br>19.9: Antimicrobial Stewardship in England<br>19.10: Antimicrobial Stewardship in France<br>19.11: Antimicrobial Stewardship in Germany<br>19.12: Antimicrobial Stewardship in Greece<br>19.13: Antimicrobial Stewardship in India<br>19.14: Antimicrobial Stewardship in Israel<br>19.15: Antimicrobial Stewardship in Italy<br>19.16: Antimicrobial Stewardship in Japan<br>19.17: Antibiotic Stewardship in the Netherlands<br>19.18: Antimicrobial Stewardship in Scotland<br>19.19: Antimicrobial Stewardship in Slovenia<br>19.20: Antimicrobial Stewardship in South Africa<br>19.21: Antimicrobial Stewardship in Argentina<br>19.22: Antimicrobial Stewardship in Spain<br>19.23: Antibiotic Stewardship in Sweden<br>19.24: Antimicrobial Stewardship in Switzerland<br>19.25: Antimicrobial Stewardship in Turkey<br>19.26: Antimicrobial Stewardship in the United States</p> <p>Section E: Research and Perspectives<br>20. Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: "Through Measuring to Knowledge"<br></p>